Filter
3510
Text search:
drug
safety
Featured
Recommendations
369
New Publications
947
Language
Document type
No document type
1951
Guidelines
582
Studies & Reports
492
Manuals
196
Strategic & Response Plan
131
Fact sheets
58
Training Material
49
Situation Updates
16
Resource Platforms
11
Infographics
11
Brochures
7
Online Courses
4
App
1
Videos
1
Countries / Regions
India
181
Global
106
Kenya
105
South Africa
86
Ethiopia
81
Uganda
77
Nigeria
72
Western and Central Europe
64
Sierra Leone
61
Tanzania
59
Liberia
56
Myanmar / Burma
52
Nepal
51
Zambia
51
Latin America and the Carribbean
47
Ghana
45
Bangladesh
45
Malawi
44
Namibia
43
Africa
42
Philippines
35
Rwanda
32
Zimbabwe
27
Eastern Europe
25
Russia
23
Cambodia
22
Asia
22
Ukraine
21
Syria
20
Lesotho
20
South–East Asia Region
18
Germany
17
Indonesia
17
Botswana
17
Brazil
15
Congo, Democratic Republic of
14
Middle East and North Africa
13
Eastern Europe and Central Asia
13
USA
11
South Sudan
11
Eswatini/ Swaziland
11
East and Southern Africa
11
West and Central Africa
11
Burkina Faso
9
Haiti
9
Mozambique
9
Vietnam
9
Cameroon
8
Pakistan
8
Thailand
8
Chile
8
Guinea
7
Senegal
7
Tajikistan
7
Afghanistan
6
Yemen
6
Venezuela
6
Albania
6
Laos
6
Colombia
5
Western Pacific Region
5
Iraq
4
China
4
Sudan
4
Argentina
4
Angola
4
Georgia
4
Guinea-Bissau
3
Somalia
3
Turkey
3
Peru
3
Switzerland
3
Libya
3
Sri Lanka
3
Paraguay
3
Bhutan
3
Moldova
3
United Kingdom
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Jordan
2
Lebanon
2
Central African Republic
2
North Macedonia
2
El Salvador
2
Palestine
2
Canada
2
Timor Leste/ East Timor
2
Iran
2
Uzbekistan
2
France
2
Saudi Arabia
1
Gambia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Benin
1
Austria
1
Serbia
1
Honduras
1
Bolivia
1
Madagascar
1
Mexico
1
Fiji
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Kyrgyzstan
1
Australia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
1319
Clinical Guidelines
343
Public Health
179
Women & Child Health
153
Key Resources
132
Capacity Building
54
Pharmacy & Technologies
52
Toolboxes
HIV
341
Mental Health
317
TB
254
AMR
220
COVID-19
211
Pharmacy
158
NTDs
121
Caregiver
86
Ebola & Marburg
72
NCDs
61
Malaria
58
Planetary Health
57
Rapid Response
55
Refugee
49
Conflict
45
Global Health Education
41
Disability
29
2.0 Rapid Response
23
Cholera
20
Specific Hazards
20
Natural Hazards
19
Zika
17
Health Financing Toolbox
15
Polio
14
Social Ethics
6
Psychoactive substance use affects the functioning of the brain and leads to impaired driving
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use
...
Framework for implementation.
The END TB Strategy.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of prod
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the
...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implement
...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety a
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive
...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety a
...
The Ethiopian Food and Drug Administration (EFDA) is mandated, in the proclamation 661/2009, to ensure the safety, quality and efficacy of medicines. To achieve this, the authority has been working
...
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa
...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major bar
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...